Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer (original) (raw)

• Shi, Y. & Massagué, J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685–700 (2003).
  Article CAS PubMed Google Scholar
• Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L. & Wrana, J. L. SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell 95, 779–791 (1998).
  Article CAS PubMed Google Scholar
• Xu, L., Kang, Y., Col, S. & Massagué, J. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFβ signaling complexes in the cytoplasm and nucleus. Mol. Cell 10, 271–282 (2002).
  Article CAS PubMed Google Scholar
• Xiao, Z., Liu, X., Henis, Y. I. & Lodish, H. F. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. Proc. Natl Acad. Sci. USA 97, 7853–7858 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, J. W., Fairman, R., Penry, J. & Shi, Y. Formation of a stable heterodimer between Smad2 and Smad4. J. Biol. Chem. 276, 20688–20694 (2001).
  Article CAS PubMed Google Scholar
• Wu, J. W. et al. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-β signaling. Mol. Cell 8, 1277–1289 (2001).
  Article CAS PubMed Google Scholar
• Inman, G. J. & Hill, C. S. Stoichiometry of active smad-transcription factor complexes on DNA. J. Biol. Chem. 277, 51008–51016 (2002).
  Article CAS PubMed Google Scholar
• Chen, X., Rubock, M. J. & Whitman, M. A transcriptional partner for MAD proteins in TGF-β signalling. Nature 383, 691–696 (1996).
  Article CAS PubMed Google Scholar
• Hata, A. et al. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100, 229–240 (2000).
  Article CAS PubMed Google Scholar
• Zavadil, J. et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc. Natl Acad. Sci. USA 98, 6686–6691 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Kang, Y., Chen, C. R. & Massagué, J. A self-enabling TGFβ response coupled to stress signaling. Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11, 915–926 (2003).
  Article CAS PubMed Google Scholar
• Massagué, J. & Wotton, D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19, 1745–1754 (2000).
  Article PubMed PubMed Central Google Scholar
• Chen, C. R., Kang, Y., Siegel, P. M. & Massagué, J. E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression. Cell 110, 19–32 (2002). Identifies a preformed cytoplasmic complex — containing E2F4/5, p107 and SMAD3 — that mediates the rapid downregulation of c-MYC and functions upstream of CDK activity and independently of cell-cycle arrest.
  Article CAS PubMed Google Scholar
• Ten Dijke, P., Goumans, M. J., Itoh, F. & Itoh, S. Regulation of cell proliferation by Smad proteins. J. Cell Physiol. 191, 1–16 (2002).
  Article CAS PubMed Google Scholar
• Inman, G. J., Nicolas, F. J. & Hill, C. S. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor activity. Mol. Cell 10, 283–294 (2002). This study demonstrates that activated SMAD proteins undergo rapid dephosphorylation and TGF-β-receptor-mediated rephosphorylation, and reveals a mechanism that determines the duration of the TGF-β signal.
  Article CAS PubMed Google Scholar
• Ebisawa, T. et al. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276, 12477–12480 (2001).
  Article CAS PubMed Google Scholar
• Tajima, Y. et al. Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-β signaling by Smad7. J. Biol. Chem. 278, 10716–10721 (2003).
  Article CAS PubMed Google Scholar
• Di Guglielmo, G. M., Le Roy, C., Goodfellow, A. F. & Wrana, J. L. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nature Cell Biol. 5, 410–421 (2003).
  Article CAS PubMed Google Scholar
• Zhu, H., Kavsak, P., Abdollah, S., Wrana, J. L. & Thomsen, G. H. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687–693 (1999).
  Article CAS PubMed Google Scholar
• Lo, R. S. & Massagué, J. Ubiquitin-dependent degradation of TGF-β-activated smad2. Nature Cell Biol. 1, 472–478 (1999).
  Article CAS PubMed Google Scholar
• Engel, M. E., McDonnell, M. A., Law, B. K. & Moses, H. L. Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J. Biol. Chem. 274, 37413–37420 (1999).
  Article CAS PubMed Google Scholar
• Hocevar, B. A., Brown, T. L. & Howe, P. H. TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18, 1345–1356 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, L., Hebert, M. C. & Zhang, Y. E. TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J. 21, 3749–3759 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Itoh, S. et al. Elucidation of Smad requirement in transforming growth factor-β type I receptor-induced responses. J. Biol. Chem. 278, 3751–3761 (2003).
  Article CAS PubMed Google Scholar
• Yamaguchi, K. et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008–2011 (1995).
  Article CAS PubMed Google Scholar
• Bhowmick, N. A. et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27–36 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Takekawa, M. et al. Smad-dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF-β. EMBO J. 21, 6473–6482 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Petritsch, C., Beug, H., Balmain, A. & Oft, M. TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest. Genes Dev. 14, 3093–3101 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kretzschmar, M., Doody, J. & Massagué, J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389, 618–622 (1997).
  Article CAS PubMed Google Scholar
• Kretzschmar, M., Doody, J., Timokhina, I. & Massagué, J. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev. 13, 804–816 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Lehmann, K. et al. Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14, 2610–2622 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Janda, E. et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156, 299–313 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Saha, D., Datta, P. K. & Beauchamp, R. D. Oncogenic ras represses transforming growth factor-β/Smad signaling by degrading tumor suppressor Smad4. J. Biol. Chem. 276, 29531–29537 (2001).
  Article CAS PubMed Google Scholar
• Foletta, V. C. et al. Direct signaling by the BMP Type II Receptor via the cytoskeletal regulator LIMK1. J. Cell Biol. 16, 1089–1098 (2003).
  Article CAS Google Scholar
• Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359, 693–699 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Kulkarni, A. B. et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Sci. USA 90, 770–774 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Cui, W. et al. Concerted action of TGF-β1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev. 9, 945–955 (1995).
  Article CAS PubMed Google Scholar
• Wang, X. J., Liefer, K. M., Tsai, S., O'Malley, B. W. & Roop, D. R. Development of gene-switch transgenic mice that inducibly express transforming growth factor β1 in the epidermis. Proc. Natl Acad. Sci. USA 96, 8483–8488 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, X. et al. Conditional epidermal expression of TGFβ 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc. Natl Acad. Sci. USA 98, 9139–9144 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, X. J. Role of TGFβ signaling in skin carcinogenesis. Microsc. Res. Tech. 52, 420–429 (2001).
  Article PubMed Google Scholar
• Dickson, M. C. et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-β 1 knock out mice. Development 121, 1845–1854 (1995).
  CAS PubMed Google Scholar
• Oshima, M., Oshima, H. & Taketo, M. M. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179, 297–302 (1996).
  Article CAS PubMed Google Scholar
• Larsson, J. et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice. EMBO J. 20, 1663–1673 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Roberts, A. B. et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. USA 83, 4167–4171 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, E. Y. & Moses, H. L. Transforming growth factor β 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol. 111, 731–741 (1990).
  Article CAS PubMed Google Scholar
• Oh, S. P. et al. Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc. Natl Acad. Sci. USA 97, 2626–2631 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Goumans, M. J. et al. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21, 1743–1753 (2002). Demonstrates that activation of ALK1 in endothelial cells can promote their proliferation and invasiveness, whereas ALK5 activation in the same cells reduces proliferation and invasiveness. These results might provide a basis for explaining the contradictory effects of TGF-β on endothelial cells that have been reported in the literature.
  Article CAS PubMed PubMed Central Google Scholar
• Diebold, R. J. et al. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated. Proc. Natl Acad. Sci. USA 92, 12215–12219 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Letterio, J. J. et al. Autoimmunity associated with TGF-β1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98, 2109–2119 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Kobayashi, S. et al. β2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-β1 null mouse. J. Immunol. 163, 4013–4019 (1999).
  CAS PubMed Google Scholar
• Brabletz, T. et al. Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol. Cell Biol. 13, 1155–1162 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Sillett, H. K., Cruickshank, S. M., Southgate, J. & Trejdosiewicz, L. K. Transforming growth factor-β promotes 'death by neglect' in post-activated human T cells. Immunology 102, 310–316 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Gorelik, L. & Flavell, R. A. Transforming growth factor-β in T-cell biology. Nature Rev. Immunol. 2, 46–53 (2002).
  Article CAS Google Scholar
• Tzachanis, D. et al. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nature Immunol. 2, 1174–1182 (2001).
  Article CAS Google Scholar
• Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M. & Massagué, J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62, 175–185 (1990).
  Article CAS PubMed Google Scholar
• Blain, S. W., Montalvo, E. & Massague, J. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272, 25863–25872 (1997).
  Article CAS PubMed Google Scholar
• Datto, M. B. et al. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl Acad. Sci. USA 92, 5545–5549 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Reynisdottir, I., Polyak, K., Iavarone, A. & Massagué, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9, 1831–1845 (1995).
  Article CAS PubMed Google Scholar
• Hannon, G. J. & Beach, D. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257–261 (1994).
  Article CAS PubMed Google Scholar
• Staller, P. et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nature Cell Biol. 3, 392–399 (2001).
  Article CAS PubMed Google Scholar
• Seoane, J. et al. TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nature Cell Biol. 3, 400–408 (2001). References 60 and 61 identify a role for MIZ1 and c–MYC in the repression of INK4B expression.
  Article CAS PubMed Google Scholar
• Seoane, J., Le, H. V. & Massagué, J. Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419, 729–734 (2002).
  Article CAS PubMed Google Scholar
• Feng, X. H., Lin, X. & Derynck, R. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β. EMBO J. 19, 5178–5193 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Polyak, K. et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59–66 (1994).
  Article CAS PubMed Google Scholar
• Reynisdottir, I. & Massagué, J. The subcellular locations of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11, 492–503 (1997).
  Article CAS PubMed Google Scholar
• Alexandrow, M. G. & Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res. 55, 1452–1457 (1995).
  CAS PubMed Google Scholar
• Norton, J. D. ID helix–loop–helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113, 3897–3905 (2000).
  CAS PubMed Google Scholar
• Lasorella, A., Noseda, M., Beyna, M., Yokota, Y. & Iavarone, A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407, 592–598 (2000).
  Article CAS PubMed Google Scholar
• Siegel, P. M., Shu, W. & Massague, J. Mad upregulation and Id2 repression accompany TGF-β mediated epithelial cell growth suppression. J. Biol. Chem. 278, 35444–35450.
• Tachibana, I. et al. Overexpression of the TGFβ-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J. Clin. Invest. 99, 2365–2374 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Jang, C. W. et al. TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase. Nature Cell Biol. 4, 51–58 (2002).
  Article CAS PubMed Google Scholar
• Valderrama-Carvajal, H. et al. Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nature Cell Biol. 4, 963–969 (2002). References 70–72 are among the first to identify TGF-β-responsive genes that contribute to TGF-β-induced apoptosis.
  Article CAS PubMed Google Scholar
• Huang, Y. et al. Transforming growth factor-β1 suppresses serum deprivation-induced death of A549 cells through differential effects on c-Jun and JNK activities. J. Biol. Chem. 275, 18234–18242 (2000).
  Article CAS PubMed Google Scholar
• Shin, I., Bakin, A. V., Rodeck, U., Brunet, A. & Arteaga, C. L. Transforming growth factor β enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol. Biol. Cell 12, 3328–3339 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Larisch, S. et al. A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif. Nature Cell Biol. 2, 915–921 (2000).
  Article CAS PubMed Google Scholar
• Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F. & Weinberg, R. A. TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nature Cell Biol. 3, 708–714 (2001).
  Article CAS PubMed Google Scholar
• Schuster, N. & Krieglstein, K. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res. 307, 1–14 (2002).
  Article CAS PubMed Google Scholar
• Derynck, R., Akhurst, R. J. & Balmain, A. TGF-β signaling in tumor suppression and cancer progression. Nature Genet. 29, 117–129 (2001).
  Article CAS PubMed Google Scholar
• Massagué, J., Blain, S. W. & Lo, R. S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103, 295–309 (2000).
  Article PubMed Google Scholar
• Wakefield, L. M. & Roberts, A. B. TGF-β signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22–29 (2002).
  Article CAS PubMed Google Scholar
• Markowitz, S. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336–1338 (1995).
  Article CAS PubMed Google Scholar
• Lu, S. L., Zhang, W. C., Akiyama, Y., Nomizu, T. & Yuasa, Y. Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res. 56, 4595–4598 (1996).
  CAS PubMed Google Scholar
• Myeroff, L. L. et al. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55, 5545–5547 (1995).
  CAS PubMed Google Scholar
• Izumoto, S. et al. Microsatellite instability and mutated type II transforming growth factor-β receptor gene in gliomas. Cancer Lett. 112, 251–256 (1997).
  Article CAS PubMed Google Scholar
• Tomita, S. et al. Analyses of microsatellite instability and the transforming growth factor-β receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features. Breast Cancer Res. Treat. 53, 33–39 (1999).
  Article CAS PubMed Google Scholar
• Furuta, K. et al. Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma. Int. J. Cancer 81, 851–853 (1999).
  Article CAS PubMed Google Scholar
• Grady, W. M. et al. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res. 59, 320–324 (1999).
  CAS PubMed Google Scholar
• Wang, D. et al. Analysis of specific gene mutations in the transforming growth factor-β signal transduction pathway in human ovarian cancer. Cancer Res. 60, 4507–4512 (2000).
  CAS PubMed Google Scholar
• Chen, T., Carter, D., Garrigue-Antar, L. & Reiss, M. Transforming growth factor β type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res. 58, 4805–4810 (1998).
  CAS PubMed Google Scholar
• Goggins, M. et al. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res. 58, 5329–5332 (1998).
  CAS PubMed Google Scholar
• Schiemann, W. P., Pfeifer, W. M., Levi, E., Kadin, M. E. & Lodish, H. F. A deletion in the gene for transforming growth factor β type I receptor abolishes growth regulation by transforming growth factor β in a cutaneous T-cell lymphoma. Blood 94, 2854–2861 (1999).
  CAS PubMed Google Scholar
• Pasche, B. et al. TβR-I(6A) is a candidate tumor susceptibility allele. Cancer Res. 59, 5678–5682 (1999).
  CAS PubMed Google Scholar
• Cui, W. et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531–542 (1996). One of the first demonstrations that TGF-β can exert tumour-suppressive as well as tumour-promoting effects, using a transgenic model of skin carcinogenesis.
  Article CAS PubMed Google Scholar
• Pierce, D. F., Jr. et al. Mammary tumor suppression by transforming growth factor β 1 transgene expression. Proc. Natl Acad. Sci. USA 92, 4254–4258 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Gorska, A. E., Joseph, H., Derynck, R., Moses, H. L. & Serra, R. Dominant-negative interference of the transforming growth factor β type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ. 9, 229–238 (1998).
  CAS PubMed Google Scholar
• Bottinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K. & Wakefield, L. M. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[_a_]-anthracene. Cancer Res. 57, 5564–5570 (1997).
  CAS PubMed Google Scholar
• Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J. & Massague, J. Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl Acad. Sci. USA 100, 8430–8435 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350–353 (1996).
  Article CAS PubMed Google Scholar
• Schutte, M. et al. DPC4 gene in various tumor types. Cancer Res. 56, 2527–2530 (1996).
  CAS PubMed Google Scholar
• Miyaki, M. et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18, 3098–3103 (1999).
  Article CAS PubMed Google Scholar
• Howe, J. R. et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280, 1086–1088 (1998).
  Article CAS PubMed Google Scholar
• Woodford-Richens, K. et al. Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium. Cancer Res. 60, 2477–2482 (2000).
  CAS PubMed Google Scholar
• Takaku, K. et al. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res. 59, 6113–6117 (1999).
  CAS PubMed Google Scholar
• Xu, X. et al. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19, 1868–1874 (2000).
  Article CAS PubMed Google Scholar
• Takaku, K. et al. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92, 645–656 (1998).
  Article CAS PubMed Google Scholar
• Hohenstein, P. et al. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene. Genes Chromosom. Cancer 36, 273–282 (2003).
  Article CAS PubMed Google Scholar
• Uchida, K. et al. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 56, 5583–5585 (1996).
  CAS PubMed Google Scholar
• Eppert, K. et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543–552 (1996).
  Article CAS PubMed Google Scholar
• Hamamoto, T. et al. Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice. Cancer Res. 62, 5955–5961 (2002).
  CAS PubMed Google Scholar
• Zhu, Y., Richardson, J. A., Parada, L. F. & Graff, J. M. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703–714 (1998).
  Article CAS PubMed Google Scholar
• Yang, X. et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18, 1280–1291 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Datto, M. B. et al. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol. Cell Biol. 19, 2495–2504 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Factor, V. M. et al. Constitutive expression of mature transforming growth factor β1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Cancer Res. 57, 2089–2095 (1997).
  CAS PubMed Google Scholar
• Bandyopadhyay, A. et al. A soluble transforming growth factor β type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Cancer Res. 59, 5041–5046 (1999).
  CAS PubMed Google Scholar
• Muraoka, R. S. et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 109, 1551–1559 (2002). Describes the use of a soluble inhibitor that binds and neutralizes TGF-β to impair mammary tumour metastasis without accelerating mammary tumorigenesis in transgenic mice.
  Article CAS PubMed PubMed Central Google Scholar
• Yang, Y. A. et al. Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects. J. Clin. Invest. 109, 1607–1615 (2002). An inhibitor similar to that used in reference 115 was expressed as a transgene in the mammary glands of transgenic mice. Mammary tumorigenesis was not affected by expression of the inhibitor in an ErbB2 transgenic tumour model, but the ability of tumour cells to metastasize to the lungs was reduced. Interestingly, no evidence of inflammatory side effects was observed from the systemic distribution of the Tgf-β inhibitor.
  Article CAS PubMed PubMed Central Google Scholar
• Oft, M., Heider, K. H. & Beug, H. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8, 1243–1252 (1998).
  Article CAS PubMed Google Scholar
• Yin, J. J. et al. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103, 197–206 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Torre-Amione, G. et al. A highly immunogenic tumor transfected with a murine transforming growth factor type β 1 cDNA escapes immune surveillance. Proc. Natl Acad. Sci. USA 87, 1486–1490 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Gorelik, L. & Flavell, R. A. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells. Nature Med. 7, 1118–1122 (2001). Demonstrates that activation of the TGF-β pathway in T cells by tumour-derived TGF-β compromises T-cell-mediated antitumour immunity. A dominant-negative TGF-β type II receptor, when expressed in T cells, allowed for the rapid and complete clearance of injected tumour cells.
  Article CAS PubMed Google Scholar
• Geissmann, F. et al. TGF-β1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162, 4567–4575 (1999).
  CAS PubMed Google Scholar
• Geiser, A. G. et al. Transforming growth factor β 1 (TGF-β 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β 1 null mouse phenotype. Proc. Natl Acad. Sci. USA 90, 9944–9948 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Dong, Y., Tang, L., Letterio, J. J. & Benveniste, E. N. The Smad3 protein is involved in TGF-β inhibition of class II transactivator and class II MHC expression. J. Immunol. 167, 311–319 (2001).
  Article CAS PubMed Google Scholar
• Wallick, S. C., Figari, I. S., Morris, R. E., Levinson, A. D. & Palladino, M. A. Immunoregulatory role of transforming growth factor β (TGF-β) in development of killer cells: comparison of active and latent TGF-β 1. J. Exp. Med. 172, 1777–1784 (1990).
  Article CAS PubMed Google Scholar
• Arteaga, C. L. et al. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression. J. Clin. Invest. 92, 2569–2576 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, J. J., Sun, Y. & Nabel, G. J. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282, 1714–1717 (1998).
  Article CAS PubMed Google Scholar
• de Jong, J. S., van Diest, P. J., van der Valk, P. & Baak, J. P. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer II: correlations with proliferation and angiogenesis. J. Pathol. 184, 53–57 (1998).
  Article CAS PubMed Google Scholar
• Hasegawa, Y. et al. Transforming growth factor-β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91, 964–971 (2001).
  Article CAS PubMed Google Scholar
• Stearns, M. E., Garcia, F. U., Fudge, K., Rhim, J. & Wang, M. Role of interleukin 10 and transforming growth factor β1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Clin. Cancer Res. 5, 711–720 (1999).
  CAS PubMed Google Scholar
• Tuxhorn, J. A., McAlhany, S. J., Yang, F., Dang, T. D. & Rowley, D. R. Inhibition of transforming growth factor-β activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res. 62, 6021–6025 (2002).
  CAS PubMed Google Scholar
• Bandyopadhyay, A. et al. Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells. Oncogene 21, 3541–3551 (2002).
  Article CAS PubMed Google Scholar
• Pertovaara, L. et al. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem. 269, 6271–6274 (1994).
  CAS PubMed Google Scholar
• Shimo, T. et al. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology 61, 315–322 (2001).
  Article CAS PubMed Google Scholar
• Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537–549 (2003). Shows that TGF-β further activates expression of two genes that promote breast cancer metastasis to the bone.
  Article CAS PubMed Google Scholar
• Enholm, B. et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14, 2475–2483 (1997).
  Article CAS PubMed Google Scholar
• Boyer, A. S. et al. TGFβ2 and TGFβ3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev. Biol. 208, 530–545 (1999).
  Article CAS PubMed Google Scholar
• Kaartinen, V. et al. Abnormal lung development and cleft palate in mice lacking TGF-β 3 indicates defects of epithelial-mesenchymal interaction. Nature Genet. 11, 415–421 (1995).
  Article CAS PubMed Google Scholar
• Proetzel, G. et al. Transforming growth factor-β 3 is required for secondary palate fusion. Nature Genet. 11, 409–414 (1995).
  Article CAS PubMed Google Scholar
• Oft, M. et al. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10, 2462–2477 (1996). One of the first demonstrations that TGF-β can cooperate with an activated RAS pathway in mammary tumour cells to induce an epithelial–mesenchymal transition, and enhance tumour-cell invasiveness.
  Article CAS PubMed Google Scholar
• Miettinen, P. J., Ebner, R., Lopez, A. R. & Derynck, R. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127, 2021–2036 (1994).
  Article CAS PubMed Google Scholar
• Portella, G. et al. Transforming growth factor β is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ. 9, 393–404 (1998).
  CAS PubMed Google Scholar
• Oft, M., Akhurst, R. J. & Balmain, A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nature Cell Biol. 4, 487–494 (2002). Using experimental metastasis assays, this study indicates that SMAD signalling, in concert with activated RAS, induces an epithelial–mesenchymal transition in squamous carcinoma cells that facilitates their extravastion into the lungs.
  Article CAS PubMed Google Scholar
• Thiery, J. P. Epithelial–mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442–454 (2002).
  Article CAS Google Scholar
• Comijn, J. et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267–1278 (2001).
  Article CAS PubMed Google Scholar
• Peinado, H., Quintanilla, M. & Cano, A. Transforming growth factor β 1 induces snail transcription factor in epithelial cell lines. Mechanisms for Epithelial–Mesenchymal transitions. J. Biol. Chem. 278, 21113–21123 (2003).
  Article CAS PubMed Google Scholar
• Savagner, P., Yamada, K. M. & Thiery, J. P. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 137, 1403–1419 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Hajra, K. M., Chen, D. Y. & Fearon, E. R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62, 1613–1618 (2002).
  CAS PubMed Google Scholar
• Romano, L. A. & Runyan, R. B. Slug is an essential target of TGFβ2 signaling in the developing chicken heart. Dev. Biol. 223, 91–102 (2000).
  Article CAS PubMed Google Scholar
• Chen, C. R., Kang, Y. & Massagué, J. Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor β growth arrest program. Proc. Natl Acad. Sci. USA 98, 992–999 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Dumont, N. & Arteaga, C. L. Targeting the TGFβ signaling network in human neoplasia. Cancer Cell 3, 531–536 (2003).
  Article CAS PubMed Google Scholar
• Laping, N. J. et al. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62, 58–64 (2002).
  Article CAS PubMed Google Scholar
• Inman, G. J. et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65–74 (2002).
  Article CAS PubMed Google Scholar
• Pierce, D. F., Jr. et al. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β 1. Genes Dev. 7, 2308–2317 (1993).
  Article CAS PubMed Google Scholar
• Jhappan, C. et al. Targeting expression of a transforming growth factor β 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J. 12, 1835–1845 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Nguyen, A. V. & Pollard, J. W. Transforming growth factor β3 induces cell death during the first stage of mammary gland involution. Development 127, 3107–3118 (2000).
  CAS PubMed Google Scholar
• Joseph, H., Gorska, A. E., Sohn, P., Moses, H. L. & Serra, R. Overexpression of a kinase-deficient transforming growth factor-β type II receptor in mouse mammary stroma results in increased epithelial branching. Mol. Biol. Cell 10, 1221–1234 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, X. J. et al. Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition. Proc. Natl Acad. Sci. USA 94, 2386–2391 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Ashcroft, G. S. et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nature Cell Biol. 1, 260–266 (1999). Demonstrates that SMAD3 functions as a central mediator of TGF-β-induced growth-inhibitory signals in keratinocytes, and that loss of SMAD3 results in greater keratinocyte proliferation and faster healing of incisional wounds.
  Article CAS PubMed Google Scholar
• Ko, T. C. et al. TGF-β1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression. Oncogene 16, 3445–3454 (1998).
  Article CAS PubMed Google Scholar
• Beck, P. L. et al. Transforming growth factor-β mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am. J. Pathol. 162, 597–608 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, M. S. et al. Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-β 1. Am. J. Pathol. 147, 42–52 (1995).
  CAS PubMed PubMed Central Google Scholar
• Bottinger, E. P. et al. Expression of a dominant-negative mutant TGF-β type II receptor in transgenic mice reveals essential roles for TGF-β in regulation of growth and differentiation in the exocrine pancreas. EMBO J. 16, 2621–2633 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Sanderson, N. et al. Hepatic expression of mature transforming growth factor β 1 in transgenic mice results in multiple tissue lesions. Proc. Natl Acad. Sci. USA 92, 2572–2576 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Bottinger, E. P. et al. The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice. Proc. Natl Acad. Sci. USA 93, 5877–5882 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Martikainen, P., Kyprianou, N. & Isaacs, J. T. Effect of transforming growth factor-β 1 on proliferation and death of rat prostatic cells. Endocrinology 127, 2963–2968 (1990).
  Article CAS PubMed Google Scholar
• Kundu, S. D. et al. Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-β type II dominant negative receptor. Prostate 43, 118–124 (2000).
  Article CAS PubMed Google Scholar
• Choi, M. E. & Ballermann, B. J. Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-β receptors. J. Biol. Chem. 270, 21144–21150 (1995).
  Article CAS PubMed Google Scholar
• Hyman, K. M. et al. Transforming growth factor-β1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery 132, 173–179 (2002).
  Article PubMed Google Scholar
• Leveen, P. et al. Induced disruption of the transforming growth factor β type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 100, 560–568 (2002).
  Article CAS PubMed Google Scholar
• Gorelik, L. & Flavell, R. A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171–181 (2000). Indicates that the inflammatory phenotype previously observed in Tgf-β1 −/− mice can be accounted for, in large measure, by loss of Tgf-β responsiveness in T cells.
  Article CAS PubMed Google Scholar
• Lucas, P. J., Kim, S. J., Melby, S. J. & Gress, R. E. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor. J. Exp. Med. 191, 1187–1196 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Nakao, A. et al. Blockade of transforming growth factor β/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J. Exp. Med. 192, 151–158 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Rich, J. N., Zhang, M., Datto, M. B., Bigner, D. D. & Wang, X. F. Transforming growth factor-β-mediated p15INK4B induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J. Biol. Chem. 274, 35053–35058 (1999).
  Article CAS PubMed Google Scholar